Instructions For Authors
The Indian Journal of Medical Research (IJMR) (accessible online at www.ijmr.org.in) is an open access peer-reviewed journal committed to publishing high-quality articles in line with the priorities of Indian Council of Medical Research (ICMR) in supporting and promoting biomedical research. The IJMR aims to disseminate quality biomedical research to all its readers in India as well as globally with its mission to provide a platform to publish biomedical and public health investigations of national, regional and global interest. The Journal invites articles from a wide range of potential contributors conducting research based on quantitative, qualitative or mixed-method approach. Ease of access to expanding knowledge base is ensured by the IJMR through its policy of free dissemination of contents to its readers.
The journal is registered with the following abstracting partners: CNKI (China National Knowledge Infrastructure), EBSCO Publishing Electronic Databases, Google Scholar, National Science Library, ProQuest.
The Journal is indexed with, or included in, the following: Index Medicus for South-East Asia Region, Indian Science Abstracts, MEDLINE/Index Medicus, EMBASE/ Excerpta Medica, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science
The Journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals.1 Indian Journal of Medical Research is a member journal of Committee on Publication Ethics (COPE).2 The Impact factor (2023) of IJMR is 2.7; and the Scopus Cite Score (as per SJR 2024) is 5.8
IJMR does not charge any fee for article processing.
Broad domains covered under IJMR: Cardiovascular diseases, Endocrinology, Reproductive & Child Health, Gynaecological Disorders, Virology, Bacteriology, Parasitology, Infectious Diseases, Oncology, Public Health, Basic & Laboratory Sciences, Demography & Disease Burden, Epidemiology, Biostatistics, Community Medicine, Internal Medicine, and Innovative Health Technologies.
Disciplines NOT considered for IJMR: Anatomy, plant biotechnology, computational biology, nursing sciences, dental sciences except in case of intervention studies, Ayurveda/Unani/Siddha related studies except in case of comparative studies and registered clinical trials, Radiological imaging data, hard core machine learning/deep leaning data with no projected clinical implications, surgical methodology papers, hard core receptor signalling studies, pure animal experiments with no clinical application.
Getting Started
Authors should identify the manuscript type and follow the specific preparation guidelines, as described below. Authors are to submit their manuscripts through the online submission platform available at https://editorialassist.com/ijmr.
All first-time users can first register themselves free of cost. Once registered, authors can log into their authors centre on the platform using their username and password to submit and keep track of their articles. In case of any unforeseen technical issues, the authors may contact the Technical Assistance at technical.team@editorialassist.com or the IJMR Editorial office at editorialijmr@gmail.com.
All the relevant editable source files should be submitted with every submission and revision. Provide your manuscript text in .docx format. Include a signed Copyright Transfer Form and an Author Undertaking Form with all manuscripts. IJMR scrutinizes all manuscripts through a technical check. Authors should go through the IJMR checklist for Level 1 Technical check and adhere to it. Manuscripts not clearing the technical check will be returned within 72 hours.
- To Download Level 1 Technical Checklist click here
- To Download Copyright Transfer form click here
- To Download Author Undertaking Form click here
- To Download Template of First Page File click here
- To Download Instructions to Authors click here
The Editorial Process
As part of the screening process, all submitted manuscripts to the IJMR are initially subjected to a plagiarism check. Manuscripts with significant textual similarity are returned to the author. Those manuscripts which are screened positively will be are subject to double blind peer review process. Authors need to certify in the covering letter that their manuscript has not been submitted to any other journal simultaneously. Manuscripts beyond the scope of IJMR, those not addressing a relatively novel research question, and those with gross methodological errors will be rejected without initiating the peer-review process. Those found suitable are sent to 2-3 technical reviewers and one statistical expert based on the need. Manuscripts are judged based on originality, relevance, methodological rigor, scientific merit, ethical standards and sound conclusions. After peer review, suitable manuscripts will be edited for language and style to fit IJMR guidelines.
Where an Editor/Editorial Board Member is listed as an author or has any other competing interest regarding a specific manuscript, another member of the Editorial Board will be assigned to oversee the handling of that article including peer-review, and the concerned Editorial Board member be blocked from accessing the manuscript related information from the system. These submissions will undergo the same review process as any other manuscript, irrespective of the institutional affiliations of the authors. The Editorial Board Member status of any of the authors has no bearing on editorial decisions.
Types of Manuscripts
Indian Journal of Medical Research publishes manuscripts ((based on quantitative, qualitative or mixed-method investigation approaches) in the following categories:
- Original Article
- Review Article (including Scoping/Mapping/Rapid Reviews)
- Systematic Review (including Meta-analysis)
- Health Technology Innovation (Fast Track Section)
- Perspectives/Viewpoint
- Student IJMR
- Research Briefs
- Research Correspondence
- Editorials
- Special Articles
- Letter to the Editor
Specific Details for Each Manuscript Type
1. Original Research Articles
2. Reviews
Various types of review articles are published in the IJMR including but not limited to rapid, mapping, scoping, etc. Review articles written by scientist(s)/ expert(s) working in a particular area and who has/have published quality original research, will be considered. The article could be up to 4000 words (excluding Abstract and References) with not more than 100 references (recent & relevant), clear methodology enumerating the search strategy employed and an unstructured abstract of about 250 words. Tables and Figures could be included as per requirement. Copyright permission should be obtained from the copyright holder in advance, if a published Table/Figure is reproduced in part or whole. Authors should consult the Editor-in-Chief before submitting, as similar reviews may already be in process.
3. Systematic Reviews (Including Meta-analysis)
The articles under this section will be critical appraisals of different studies on important topics of clinical/public health significance to obtain an unbiased quantitative estimate of the overall effect of an intervention or variable for a defined outcome. The focus could be on cause, diagnosis, prognosis, therapy, prevention, etc. These would be thoroughly researched articles giving comprehensive and balanced perspective. Systematic reviews could be about up to 2500 words with minimum number of Tables/Figures. A structured abstract of 250 words is required, including sections: Context (clinical question or issue and its significance), Objective, Evidence Acquisition (data sources used, search strategies, years searched), Results (major findings with emphasis on highest quality evidence), Limitations, and Conclusions (application of current knowledge by clinicians). The protocol of all systematic reviews submitted to IJMR should be registered in review registries such as PRISMA (https://www.prisma-statement.org/protocols), PROSPERO (https://www.crd.york.ac.uk/prospero/), etc.
4. Health Technology Innovations
Articles under this section will include research evaluating innovative indigenous low-cost health technologies with clinical validation which are seeking regulatory approval or are being recommended for adoption by national health programmes. The manuscripts found suitable for consideration under this section by the Editors will undergo peer-review. To ensure high quality, its acceptance depends on satisfactory reviews with comments that can be quickly addressed by the authors and rapid revision by the authors within 7 days. Accepted manuscripts will be published online within 6 weeks of submission. These manuscripts would be about 1500-2000 words (excluding Title, Abstract and References) and contain a 4-point structured abstract (similar to Original Articles) of 200-250 words, a combined Results & Discussion section not exceeding 500 words, maximum of 25 references and one Figure or 1-2 Tables. Work that has been completed within 6 months of manuscript submission will be given preference.
The manuscripts being submitted for this section must be accompanied by a Letter/Correspondence with regulatory authority from whom approval is being sought, or from the concerned authority recommending adoption of technology to the Government or the need for peer-reviewed efficacy data for the technology. Manuscripts having clinical evaluation will be required to submit a letter of approval from an Institutional Ethics Committee.
5. Perspectives/ Viewpoint
Articles should address current controversial and challenging topics in health care. These could be an intersection between topics in medicine and the society. These are primarily opinion pieces written by senior scientists, public health experts and policy makers with sufficient credible experience and recognition on the subject. Such papers will be generally written by a single author. These should not exceed 1500 words and are subject to peer review. Support views with evidence and references.
6. Student IJMR
Aimed to encourage and promote the participation of students in medical research, this section is meant exclusively for medical undergraduate students. This section would also include reports of important scientific developments that will impact patient care, public health and/or career advancement. This section may also carry Abstracts of research done by students as part of ICMR’s Short Term Studentship, DST’s Kishore Vaigyanik Protsahan Yojana, etc. The length of the papers should not be more than 1000 words. All the content in this section will be published subject to peer review.
7. Research Brief
Original research manuscripts containing well defined study design and sample size; or submissions with preliminary investigative data with limited methodology and sample size but having important clinical implications can be submitted as Research Briefs. These would be about 1500-2000 words and contain a 4-point structured abstract (like Original Articles) of 150-200 words. A Research Brief can have 1-2 Tables/Figures.
8. Research Correspondence
A Research Correspondence would be either a preliminary/pilot study or a post-implicative report of around 1000 words with an unstructured Abstract of 100 words. A Research Correspondence would be containing either a Table or a Figure.
9. Editorials
These are solicited pieces related to a current topic or related to an article published in the same issue of the Journal. Editorials will be around 1000 words with 10 references and no abstract.
10. Special Articles
This section includes reviews on Medical Education, Medical Ethics, Health Economics, Digital Health, and any pertinent topics of current interest. The specific instructions for authors for review articles will be applicable.
11.Letters to Editor
Letters on recent articles in IJMR are welcome within 3 months of publication. The Editor may seek a reply from the authors and publish the letter and reply after review. Each letter must have a distinct title and should not exceed 500 words with up to 5 recent references.
Submission of Manuscript
For reporting of research, the authors are expected to comply with the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations) by the International Committee of Medical Journal Editors” (ICMJE) (www.icmje.org)1. In addition to this, authors are to adhere to the recommended standard reporting guidelines based on the study design of the submitted article (www.equator-network.org)3.
Contributors may consult the following Guidelines for specific study designs:
The reporting guidelines for other types of studies can be found at https://www.equator-network.org/reporting-guidelines/.
Sr. No. | Type of Study | Source |
---|---|---|
1 | Randomized controlled trials (RCTs) | CONSORT – http://www.consort-statement.org |
2 | Systematic reviews & meta-analysis | PRISMA Guidelines – http://www.prisma-statement.org |
3 | Observational studies in epidemiology | STROBE – http://www.strobe-statement.org/ |
4 | Meta-analysis of observational studies in epidemiology | MOOSE – http://statswrite.eu/pdf/MOOSE%20Statement.pdf |
5 | Studies on diagnostic accuracy | STARD – http://www.stard-statement.org |
* For any other type of study contributors may consult ICMJE website (www.icmje.org)
- The manuscript is to be submitted electronically at https://editorialassist.com/ijmr
- Use British (UK) English throughout.
- The manuscript should be typed in ‘portrait’ layout, 1.5 spacing, with a 2.5 cm margin, 12-point Times New Roman font, and justified. The pages of the manuscript should be numbered (bottom-centre alignment).
- All abbreviations used in text should be expanded upon first use (acronym in parentheses) in the title, abstract, and text separately unless the abbreviation is a standard unit of measure. The use of acronyms and abbreviations must be kept to a minimum.
- Non-proprietary names of drugs, devices, and other products should be used. If proprietary names are provided, they should not include superscript ©, TM, or ® symbols; only the first letter should be capitalized. This should be followed by the name of the manufacturer in parentheses.
- Units: Use conventional units for measurement. Prefer the metric system for length, area, mass, and volume.
Organization of Sections in an Article
All manuscripts submitted for publication to the IJMR should include the following: (1) First page file; (2) Blinded Manuscript file; (3) Tables & Figures; (4) A scanned copy of ethical clearance certificate; (5) Undertaking by authors & copyright transfer agreement. Details are given below.
1. FIRST PAGE FILE / COVER PAGE
This should include a Covering letter, Title page and Author’s contribution in a single file.
- The covering letter should explain why the paper should be published in the IJMR, rather than a specialty journal. One of the authors should be identified as the corresponding author of the paper, who would be responsible for the contents of the paper and for communication with the Editorial office. Author should declare that the article was not published or under consideration, in part or whole, simultaneously in any other journal or proceedings.
Title page: should include the following:
- Title of the article: It should be concise and informative; the type of study may be added in the title after a colon.
- Include a Running title of maximum 40 characters
- Full names (First name and Surname), highest academic degrees, and designations of all authors at the time of the work. Include mobile numbers, email addresses, and ORCID numbers if available.
- Department(s) and institution(s) to which the work should be attributed (This should mention the institution of affiliation at the time of conduct of the study, not your current affiliation)
- Name, address and e-mail of the corresponding author
- Contributors’ credits
- Declaration on competing interests
- Funding: source(s) of support in the form of grants, equipment, drugs or all of these
- Ethical clearance status, including the Ethics Committee’s name, date, and number of clearance (ensure the committee is registered with the regulatory body)
- Clinical trial registration number in cases of clinical trials
- STS number in case of Student IJMR
- Data sharing statement for all original research
- Declaration of Artificial Intelligence (AI) in scientific writing
- Word count (excluding abstract, tables, figures, acknowledgments, key messages, and references)
- Number of Tables and Number of Figures
- Disclaimers, if any
Authorship Criteria: All authors must meet all the following ICMJE’s four criteria:
- Significant contributions to the work’s conception, design, data acquisition, analysis, or interpretation;
- Drafting or critically revising for intellectual content;
- Final approval of the version to be published; AND
- Accountability for all work aspects, ensuring integrity and resolving questions.
Group Authorship: If only the group’s name is given, all members must meet the authorship criteria. If some individual names are followed by the group name linked with ‘and/&’, all members must meet the criteria. If linked with ‘for’, only the named authors need to meet the criteria. List other members as collaborators in an Annexure.
Change in Authorship: The list of authors and the order of authors should be finalized before submission to the Indian Journal of Medical Research. Any requests to add, remove, or reorder author names after submission must be e-mailed to the Editorial Office by the corresponding author of the manuscript with a valid reason. All authors must individually send confirmation e-mails agreeing with the change.
Declaration of AI in Scientific Writing: AI technologies, including Large Language Models like ChatGPT, can be used to improve language but must be documented in the methods section. AI should not be listed as an author.
Competing Interests: Authors must disclose any ties that could influence their judgment when submitting a manuscript. Important competing interests include financial relationships with the industry, such as employment, consultancies, stock ownership, honoraria, grants, or expert testimony, either directly or through immediate family.
If an editorial board member has a conflict of interest with any manuscript that they are handling, the same needs to be communicated to the Editor-in-Chief, so that the manuscript can be handled appropriately.
Committee on Publication Ethics (COPE) and ICMJE guidelines are followed for author disputes and ethical issues.1,2
Funding: Authors must disclose all sources of financial and material support for the research work, including grant numbers and funding agencies.
Duplicate/Simultaneous/Prior Publication: Submission of a manuscript to the journal implies that the work described has not been previously published and is not under consideration for publication elsewhere. Any prior publication, such as an abstract in a conference abstract book or as an academic thesis, must be disclosed upfront in the cover letter. Authors must affirm that the paper is original work conducted at the affiliated institution, and that it has been reviewed and approved by all authors before submission to IJMR.
Data Sharing Statement: Your statement should typically include:
- where the data can be accessed (preferably a data repository such as CORD in CERES)
- an identifier, such as a Digital Object Identifier (DOI) or accession number, or an active web link to the permanent record for the dataset
- details of any restrictions on the access to the data and an accompanying justification (e.g., for commercial, legal or ethical reasons).
2. ARTICLE (BLINDED MANUSCRIPT) FILE
No author or institution name should appear in any part of the manuscript in this file.
Abstract and Key words:
Since abstracts are the only substantive portion of an article indexed in several electronic databases, and the only portion many readers read, authors need to ensure that these accurately reflect the content of the article. All Original research and Brief Research should have a 4-point structured abstract as indicated above. Abstract should be brief and indicate the scope and significant results of the paper. It should only highlight the principal findings and conclusions so that it can be used by abstracting services without modification. Conclusions and recommendations not found in the text of the articles should not be inserted in the Abstract.
Key words
A set of suitable Key words (4-6 in number) should be provided in alphabetical order below the abstract to facilitate indexing. Terms from the Medical Subject Headings (MESH) list of National Library of Medicine should preferably be used. Do not repeat words already included in the title.
Introduction
Introduction should be brief and state precisely the scope of the paper. Review of the literature should be restricted to reasons for undertaking the present study and provide only the most essential background. The objective of the study should be written clearly with adequate justification at the end of this section.
Methods
The 10 important components of the methods section should preferably be included viz., study setting, study duration, study population, study design, participant selection, outcome variables, sample size, intervention & follow-up, statistical analysis, and ethical issues. The methods section should logically describe the study’s design, execution (e.g., participant selection, intervention, outcome measures, ethical considerations, data collection), and data analysis (e.g., study power estimate, statistical tests). For standard methods, references suffice unless modifications are made, which should be detailed. Authors must provide complete details for any new methods or apparatus. Use commercial names of drugs/equipment once with a capital letter and manufacturer’s name in parentheses; thereafter, use the scientific name.
Use of Artificial Intelligence:
Authors using AI technology for conducting the study should detail its use in the methods section in sufficient detail to enable replication of the approach. including the tool used, version, and prompts where applicable.
Clinical trial:
Manuscripts on randomized controlled trials (RCTs) should include a CONSORT flow diagram showing patient progress throughout the trial.
Trial registration: The registration status and number must be included on the title page of all interventional studies.
Study design: Selection of the observational or experimental participants (patients or laboratory animals, including controls, whether randomly or consecutively) and basis of sample size calculation should be mentioned clearly, including eligibility and exclusion criteria and a description of the source population.
Contributors may consult the standard reporting guidelines depending on the study design of the submitted article at www.equator-network.org.
Statistical analysis: The statistical analysis done and statistical significance of the findings when appropriate, should be mentioned. Unless absolutely necessary for a clear understanding of the article, detailed description of statistical treatment may be avoided. Articles based heavily on statistical considerations, however, need to give details particularly when new or uncommon methods are employed. For standard and routine statistical methods employed, authors need to give only authentic references. Specify any general use computer programs used.
Abbreviations and symbols: Use standard abbreviations only. Avoid abbreviations in the title and abstract unless necessary. Provide the expanded form of an abbreviation before its first use in the text, except for standard units of measurement. Year, month, week, day, hour, minute, and second should be abbreviated as y, mo, wk, d, h, min, and s respectively in tables and figures, but not in text. Abbreviations should follow the International System of Units (SI) throughout the text, tables, and figures.
Discussion
The discussion should deal with the interpretation of results without repeating the information already presented under Results. It should relate new findings to the known ones and include logical deductions. It should also mention any weaknesses/limitations/lacunae of the study.
Generally, this section should not exceed one-fourth of the manuscript’s total length. Avoid conducting an extensive review of the literature. This section should include the following unheaded paragraphs in the specified order: (i) a summary of the major findings, (ii) an evaluation of the study’s limitations and strengths, (iii) a comparison with other similar studies, and (iv) the generalizability of the findings as well as their implications for practice, policy, or research.
Claiming of priority on work that is ongoing should also be avoided. Recommendations may be included as part of the Discussion, only when considered absolutely necessary and relevant. This section should preferably end with a concluding remark. Conclusions should be linked to the goals of the study. Avoid unqualified statements and conclusions not completely supported by the data. Distinguish between clinical and statistical significance and refrain from making statements on economic benefits and costs unless their manuscript includes economic data and analyses.
References should be numbered consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by Arabic numerals in parentheses. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. The titles of journals should be abbreviated according to the style used for MEDLINE (www.ncbi.nlm.nih.gov/nlmcatalog/journals). Ensure that all hyperlinks have been removed from references.
References to literature cited should be numbered consecutively and placed at the end of the manuscript. In the text they should be inserted as superscripts (after the punctuation mark, if needed). As far as possible mentioning names of author(s) under references should be avoided in text. The titles of the journals should be abbreviated according to the style used by the PubMed. Journals not indexed in Medline/PubMed should be cited in full names.
3. TABLES
Tables should be included in main Article file in MS Word file format. Tables should be numbered consecutively with Roman numerals (I, II, III, etc). They should bear a brief title and column headings should also be short. Units of measurement should be abbreviated and placed below the headings. Statistical measurement variations such as SD and SE should be identified. Inclusion of structural formulae in Tables should be avoided.
Tables should be structured to have between three and five columns, and between four and sixteen rows. Tables that do not meet these criteria or exceed the space of a single journal page will be considered for inclusion as web tables at the editorial team’s discretion.
Authors should use footnotes for explanatory matter and avoid placing them in headings. Explain nonstandard abbreviations in footnotes and use symbols (*, †, ‡, §) if needed. Ensure each table is cited in the text.
4. FIGURES AND ILLUSTRATIONS
All images should be uploaded in JPEG, or TIF, format. The file size should be within 20 MB in size. Figures should be numbered consecutively according to the order in which they have been first cited in the text. Labels, numbers, and symbols should be clear and of uniform size. The lettering for figures should be large enough to be legible after reduction to fit the width of a printed column. Symbols, arrows, or letters used in photomicrographs should contrast with the background and should be marked neatly with transfer type or by tissue overlay and not by pen. Titles and detailed explanations belong in the legends for figures not on the figure/image themselves. The photographs and figures should be trimmed to remove all the unwanted areas and the patient’s name and medical record number. If photographs of individuals are used, their pictures must be accompanied by written permission to use the photograph and eyes must be covered. If a figure has been published elsewhere, the original source must be acknowledged and written permission from the copyright holder submitted to reproduce the material. A credit line should appear in the legend for such figures. Electronic manipulation of images that materially alters the medical information must be identified and the nature of the alterations described. Symbols used must be uniform in size and style and large enough to withstand reduction. Line drawings and graphs should be in black on a white background, using the same size type as the text. 0.5 mm hairline rules must be avoided. Authors’ names and affiliations must not appear anywhere on the images.
Send figures as separate files. Use portrait format for photos to fit one column. Number figures consecutively in Arabic numerals (1, 2, 3) as cited in the text. For charts and graphs, prepare them in Word files and do not paste from programs like PowerPoint or SPSS. Provide editable files of figures as supplementary material.
5. ETHICAL CLEARANCE CERTIFICATE
All studies conducted on patients / volunteers/ Human biological material/animals should submit a scanned copy of Ethical Clearance Certificate.
6. UNDERTAKING BY AUTHOR(S) & COPYRIGHT TRANSFER AGREEMENT
It is necessary that all the authors give an undertaking (in the format specified by the journal) indicating their consent to be co-authors in the sequence indicated on the title page. Each author should give his or her name as well as the address and appointment current at the time the work was done, plus a current address for correspondence including telephone and fax numbers and email address. A senior author may sign the Undertaking by Authors for deceased co-authors or a junior author who has left the institution and whose whereabouts are not known and take the responsibility.
A paper with corporate (collective) authorship must specify the key persons responsible for the article (writing committee); others contributing to the work should be recognized separately as collaborators.
Author(s) will be asked to sign a transfer of copyright agreement, which recognizes the common interest that both journal and author(s) have in the protection of copyright. It will also allow us to tackle copyright infringements ourselves without having to go back to authors each time.
7. PROOFS
Authors of accepted articles are supplied with publisher’s proofs online on their Author centre and will also receive email alerts when proofs are available. Corrections on the page proofs should be restricted to the indicated errors only and no substantial additions/deletions should be made. No change in the names of the authors (by way of additions and deletions) is permissible at the proof stage.
8. COPYRIGHT AND OPEN ACCESS STATEMENT
All of the content published in the Indian Journal of Medical Research is protected under the International copyright law, defined by Creative Commons and International Council of Medical Journal Editors (ICMJE). The author of an article retains academic copyright of the content and can self-archive the article only after the article is first published by IJMR online for a particular issue. The journal retains the commercial rights of the published content and publisher executes the commercial rights on behalf of the journal. The journal also grants to all readers and users a free, irrevocable, and global license to copy, use, distribute and display the content publicly and to make and distribute derivative works in any digital medium for purely academic and non-commercial purpose, subject to proper attribution of authorship and ownership of the copyrights under the Creative Commons Attribution-Noncommercial-Share Alike 4.0 International Public License. However, reproduction/reuse of any article or its component in part or whole in a subsequent publication with or without commercial implications can only be done with prior permission from the Indian Council of Medical Research (ICMR), New Delhi (the hosting agency of the IJMR) on behalf of the IJMR. In this context, the ICMR retains the right to determine commercial implications for requests of reuse on a case-to-case basis. Permission to reuse any article, in part or whole if granted, will be valid for a period of one year beyond which a fresh permission needs to be obtained for the same.
Open Access Publication and Creative Commons Licensing
Indian Journal of Medical Research Indian Journal of Medical Research is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0.
Annexure I
Units of Measurements
Quantity | Base unit name | SI unit symbol |
---|---|---|
Length | meter | m |
Mass | kilogram | kg |
Time | second | s |
Electric current | ampere | A |
Thermodynamic temperature | kelvin | K |
Luminous intensity | candela | Cd |
Amount of substance | mole | mol |
Table 2: The International System of Units (SI) Derived Units and Symbols
Quantity | Base unit name | SI unit symbol | Derivation from base unit |
---|---|---|---|
Area | square meter | m2 | m2 |
Volume | Litre | L | L |
Speed, velocity | meter per second | m/s | m/s |
Density, mass density | kilogram per cubic meter | kg/m2 | kg/m2 |
Specific volume | cubic meter per kilogram | M3/kg | M3/kg |
Concentration | mole per cubic meter | mol/m3 | mol/m3 |
Frequency | hertz | Hz | S-1 |
Force | newton | N | kg m s-2 |
Pressure, stress | pascal | Pa | kg m-1s -2(N/m2) |
Work, energy | joule | J | kg m-2s -2(N-m) |
Luminous flex | lumen | Lm | m2m -2cd=cd |
Power, radiant flux | watt | W | m-2 kg s-3 (J/s) |
Electric potential | volt | V | M2 kgs-3 A-1 |
Electric charge | coulomb | C | A-s |
Electric resistance | ohm | O | m-2 kg s-3 A-2 (V/A) |
Capacitance | farad | F | m-2 kg-1 s-4 A-2 (C/V) |
Magnetic flux | weber | Wb | m-2 kg-1 s-2 A-2 (V-s) |
Magnetic flux density | tesla | T | Kg-s-2 A-1(Wb/m2) |
Inductance | henry | H | m-2 kg-s-2A-2) |
Factor | Prefix | Symbol |
---|---|---|
1024 | yotta | y |
1021 | zetta | z |
1018 | exa | e |
1015 | peta | p |
1012 | tera | t |
109 | glga | g |
106 | mega | m |
103 | kilo | k |
102 | hector | h |
101 | deka (deca) | da |
10-1 | deci | d |
10-2 | centi | c |
10-3 | milli | m |
10-6 | micro | μ |
10-9 | nano | n |
10-12 | pico | p |
10-15 | femto | f |
10-18 | atto | a |
10-21 | zepto | z |
10-24 | yocto | y |